Adynovate (Antihemophilic Factor Drug Interactions: 40 Major
Adynovate (Antihemophilic Factor (Recombinant) Pegylated) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Adynovate. Always confirm against the full prescribing information.
42 interactions
Concizumab
The risk or severity of thromboembolism can be increased when Antihemophilic factor, human recombinant is combined with Concizumab.
Level 1 evidence
Fitusiran
The risk or severity of hypercoagulability can be increased when Antihemophilic factor, human recombinant is combined with Fitusiran.
Level 1 evidence
Enter your NPI to unlock 40 major interactions for Adynovate
Adynovate (Antihemophilic Factor (Recombinant) Pegylated) has 42 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Adynovate (Antihemophilic Factor (Recombinant) Pegylated) has 40 major, 1 moderate, and 1 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Adynovate. Always confirm against the full prescribing information.